EMBAR

Author:
Yasir Nawaz, Ishart Nazar, Umer Ali , Hussnain Ahmad, Nabila Iqbal, Muhammad Kaleem Ullah ,Hafiza Rabia shaifq , Ayesha Siddiqa, Khadija iqbal
Muhammad Kaleem Ullah

Published Date: 19-Feb, 2023

Keywords: Diagnoses, Mammary secretory ,Carcinoma, sentinel lymph,Breast tumour.

Abstract:
It is concluded that breast cancer is 2nd most diagnoses disease in female in the United States. Both sexes can get disease and females are more likely to this disease. Females with age 50 to 74 were much likely to develop breast cancer. In America and England, the five-year survival rates range from 80 to 90 percent. The five-years survival rate are lower in poorer nations. There might also be nipple discharge. The majority of womenwho are diagnoses with Paget disease of the breast also have a breast lump. Mammary secretory carcinoma lesions are often tiny, painless, slow-growing ducatls breast tumours that have invaded the tissues near their duct of origin and occasionally metastasized to distant tissues. They frequently expand to sentinels lymph nodes and/or axillary’s lymph nodes. The females who received artificially hormones oestrogen and progesterone have greater risk of breast cancer. The removal of affected or cancerous cells in breast needs breast cancer surgery. A mammography’s can find the early breast tumour. The presence of lump in armpit lymph nodes is another sign of breast cancer. Treatment for those whose cancer has spreading to others bodily areamany focus on enhancedcomforts and quality’s of life.

References:

"Breast Cancer Treatment (PDQ?)". NCI. 23 May 2014. Archived from the original on 5 July 2014. Retrieved 29 June 2014.

World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 5.2. ISBN 978-92-832-0429-9

"Klinefelter Syndrome". Eunice Kennedy Shriver National Institute of Child Health and Human Development. 24 May 2007. Archived from the original on 27 November 2012.

Jump up to:a b "SEER Stat Fact Sheets: Breast Cancer". NCI. Archived from the original on 3 July 2014. Retrieved 18 June 2014.

Jump up to:a b "Cancer Survival in England: Patients Diagnosed 2007?2011 and Followed up to 2012" (PDF). Office for National Statistics. 29 October 2013. Archived (PDF) from the original on 29 November 2014. Retrieved 29 June 2014.

Jump up to:a b Sung, Hyuna; Ferlay, Jacques; Siegel, Rebecca L.; Laversanne, Mathieu; Soerjomataram, Isabelle; Jemal, Ahmedin; Bray, Freddie (2021). "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries". CA: A Cancer Journal for Clinicians. 71 (3): 209?249. doi:10.3322/caac.21660. ISSN 1542-4863. PMID 33538338. S2CID 231804598.

"Breast Cancer". NCI. January 1980. Archived from the original on 25 June 2014. Retrieved 29 June 2014.

Saunders C, Jassal S (2009). Breast cancer (1. ed.). Oxford: Oxford University Press. p. Chapter 13. ISBN 978-0-19-955869-8. Archived from the original on 25 October 2015.

G?tzsche PC, J?rgensen KJ (June 2013). "Screening for breast cancer with mammography". The Cochrane Database of Systematic Reviews. 6 (6): CD001877. doi:10.1002/14651858.CD001877.pub5. PMC 6464778. PMID 23737396.

Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, Humphrey L (November 2009). "Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force [Internet]". U.S. Preventive Services Task Force Evidence Syntheses. Rockville, MD: Agency for Healthcare Research and Quality. PMID 20722173. Report No.: 10-05142-EF-1.

Jump up to:a b Siu AL (February 2016). "Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 164 (4): 279?96. doi:10.7326/M15-2886. PMID 26757170.

"Five Things Physicians and Patients Should Question". Choosing Wisely: an initiative of the ABIM Foundation. American College of Surgeons. September 2013. Archived from the original on 27 October 2013. Retrieved 2 January 2013.

Jump up to:a b c d "Breast Cancer Treatment (PDQ?)". NCI. 26 June 2014. Archived from the original on 5 July 2014. Retrieved 29 June 2014.

Jump up to:a b "World Cancer Report" (PDF). International Agency for Research on Cancer. 2008. Archived from the original (PDF) on 20 July 2011. Retrieved 26 February 2011.

World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 1.1. ISBN 978-92-832-0429-9

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (November 2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". CA: A Cancer Journal for Clinicians. 68 (6): 394?424. doi:10.3322/caac.21492. PMID 30207593. S2CID 52188256.

"Male Breast Cancer Treatment". National Cancer Institute. 2014. Archived from the original on 4 July 2014. Retrieved 29 June 2014.

Hanahan, D. (2000). ?The hallmarks of cancer?. cell: 100(8), p. 57-70.

Malumbres, M. (2001). ?A critical decision in cancer?. Nat. Rev. Cancer: 36(2), p. 222-231.

Ormandy, C. (2003). ?Cyclin D1, EMS1 and 11q13 amplification in human breast cancers?. Breast Cancer Res. Treat: 78(2), p. 323?335.

Buckley, M. (2010). ?Expression and amplification of cyclin genes in human breast cancer?. Proc. Natl. Acad. Science: 8(5), p. 2127-2213.

Gillett, C. (2014). ?Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining?. Cancer Res.: 54(6), p. 1812-1817.